Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
2,140
NCT02607501
European eCLIPS™ Safety, Feasibility and Efficacy Study
Phase: N/A
Role: Lead Sponsor
Start: Apr 1, 2016
Completion: Sep 30, 2021
NCT03729739
Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Trial
Role: Collaborator
Start: Nov 6, 2018
Completion: Dec 31, 2025
NCT01957683
Canadian eCLIPs™ Safety and Feasibility Study Protocol
Phase: Phase 1
Start: Jan 31, 2020
Completion: Jan 31, 2022
NCT05330897
French eCLIPs™ Efficacy and Safety Investigation
Start: Dec 16, 2021
Completion: Dec 16, 2026
NCT04886505
An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms
Start: Jan 1, 2022
Completion: Sep 1, 2023